US2005176947A1PendingUtilityA1

Optical recording apparatus using one-dimensional diffractive light modulator

Priority: Feb 21, 1996Filed: Sep 28, 2004Published: Aug 11, 2005
Est. expiryFeb 21, 2016(expired)· nominal 20-yr term from priority
C07B 2200/11G11B 7/128C07K 2319/00C07K 14/20G01N 2333/20C07B 2200/05A61K 39/02A61K 38/00C07K 16/1207A61K 39/44G11B 7/00772A61K 39/40G11B 7/0065C07B 59/008G01N 33/56911Y02A50/30A61K 39/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to an optical recording apparatus, which multiplexes the radiation angles of diffracted beams through the use of a one-dimensional diffractive light modulator at the time of recording data on a holographic recording medium, etc., so that the occurrence of errors associated with a high addressing rate and spatial location for data recording is prevented, thus making a separate correction circuit and an additional device for compensating for errors unnecessary.

Claims

exact text as granted — not AI-modified
1 - 30 . (canceled)  
     
     
         31 . An isolated antibody that binds immunologically to an epitope of SEQ ID NO: 15.  
     
     
         32 . The isolated antibody of  claim 31 , further defined as a monoclonal antibody.  
     
     
         33 . The isolated antibody of  claim 31 , further defined as a polyclonal antibody.  
     
     
         34 . The isolated antibody of  claim 31 , further defined as labeled with a label.  
     
     
         35 . The isolated antibody of  claim 34 , wherein the antibody is further defined as bound to biotin.  
     
     
         36 . The isolated antibody of  claim 34 , wherein the antibody is further defined as bound to avidin.  
     
     
         37 . The isolated antibody of  claim 34 , wherein the antibody is further defined as bound to streptavidin.  
     
     
         38 . (canceled)  
     
     
         39 . The isolated antibody of  claim 34 , wherein the antibody is further defined as conjugated to a secondary binding ligand.  
     
     
         40 . The isolated antibody of  claim 34 , wherein the antibody is further defined as bound by a secondary antibody directed against the antibody.  
     
     
         41 - 43 . (canceled)  
     
     
         44 . The isolated antibody of  claim 31 , further defined as immobilized on an affinity column.  
     
     
         45 . An immunodetection kit comprising the isolated antibody of  claim 31 .  
     
     
         46 . The isolated antibody of  claim 31 , further defined as immunologically bound to a protein or polypeptide comprising an epitope of SEQ ID NO: 15.  
     
     
         47 . The isolated antibody of  claim 34 , wherein the label is radioactive.  
     
     
         48 . The isolated antibody of  claim 34 , wherein the label is chemiluminescent.  
     
     
         49 . The isolated antibody of  claim 34 , wherein the label is colorimetric.  
     
     
         50 . The isolated antibody of  claim 39 , wherein the secondary binding ligand is biotin.  
     
     
         51 . The isolated antibody of  claim 39 , wherein the secondary binding ligand is avidin.  
     
     
         52 . The isolated antibody of  claim 39 , wherein the secondary binding ligand is streptavidin.

Join the waitlist — get patent alerts

Track US2005176947A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.